Skip to content
healthcare.dev

azelaic acid

NDC 0591-2131, azelaic acid, gel, from Actavis Pharma, Inc..

Product NDC
0591-2131
Status
Listed
Labeler
Actavis Pharma, Inc.
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA208011
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2131 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AZELAIC ACID.15 g/g

Pharmacologic classes

Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]

Package NDCNDC-11Package
0591-2131-55005912131551 TUBE in 1 CARTON (0591-2131-55) / 50 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/66298d50-d4e2-4852-bbab-581389c488cb
  • NADAC price for package 00591213155

    GET /v1/drugs/nadac/00591213155

Use it

Look up 0591-2131 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0591-2131 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0591-2131. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.